Company intelligence

IOVA

Iovance Biotherapeutics, Inc. · NASDAQ · Healthcare

Price$8.44+4.71% · +$0.38

Market cap3.77BEquity value

P / E-11.6Trailing ratio

Volume11.9MLatest session

Market data

IOVA price chart

TradingView

Related signals

1 min delayed

Browse public IOVA signals with their source context and measured market impact. Open any signal for its permanent analysis page.

IOVAAug 20, 2026-4.31% since signal

IOVA Reach 52-Week High on No News; Momentum Rally warrants Caution

IOVA is trading at a 52-week high with no disclosed news to justify the move, even as shares have surged over 200% year-to-date. The absence of a catalyst raises sustainability concerns and implies potential volatility or a quick pullback if fundamentals remain sidelined. Investors should monitor for hidden catalysts and be ready for abrupt reversals.

View signal analysis

IOVAFeb 24, 2026+1.86% since signal

Iovance Biotherapeutics Shares Rise on Promising Clinical Trial Data

Iovance Biotherapeutics (IOVA) stock is rising dramatically following positive early results from a pilot trial of its tumor-infiltrating lymphocyte (TIL) therapy for advanced soft-tissue sarcomas. This catalyst could bolster investor confidence and lead to further advancements in product development.

View signal analysis

Research